Statins Market Key Highlights:
- Market Size (2024): USD 14.71 Billion
- Projected Market Size (2034): USD 17.76 Billion
- CAGR (2023-2034): 1.9%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Statins Market
The statins market is an integral branch of the healthcare industry. This industry deals with the manufacturing and distribution of fat-reducing therapies across the world. The main types of statins that are available in the market consist of synthetic statins and natural statins. It works by decreasing the amounts of low-density lipoproteins (LDL) and very low-density lipoproteins (VLDL) in the blood and increasing high-density lipoproteins (HDL) in human beings. These therapies are found in various drug classes, including atorvastatin, fluvastatin, lovastatin, rosuvastatin, simvastatin, and pitavastatin. This market is expected to rise significantly with the growth in the pharmaceutical industry around the globe.
The growing incidences of several cardiovascular diseases, such as coronary artery disease, peripheral artery disease, carotid artery disease, rheumatic heart disease, and others, have increased the demand for statins, thereby driving the market growth. Also, the rising cases of obesity across the world along with technological advancements in medical sciences, have propelled industrial growth. Moreover, the increasing demand for statins from hospitals, clinics, and others, along with the higher prevalence of inflammatory disorders among people, is expected to boost the growth of the statins market.
Advancements in the pharmacogenomics sector, along with a rising emphasis on combination therapies, are expected to create ample growth opportunities for the market players in the future. In May 2022, Zydus Lifesciences launched Bemdac. Bemdac is an acidic drug that is composed of statin and has been found effective for controlling levels of bad cholesterol in humans.
Statins Market Segmentation:
By Type
- Astrovastatin
- Fluvastatin
- Lovastatin
- Pravastatin
- Simvastatin
- Others
By Application
Statins Market Companies:
- AstraZeneca
- Pfizer
- GlaxoSmithKline
- Novartis International
- Merck
- Biocon
- Concord Biotech
- Aurobindo Pharma.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
